222 related articles for article (PubMed ID: 35802825)
21. The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trial.
Skowron G; Stein D; Drusano G; Melbourne K; Bilello J; Mikolich D; Rana K; Agosti JM; Mongillo A; Whitmore J; Gilbert MJ
J Infect Dis; 1999 Oct; 180(4):1064-71. PubMed ID: 10479132
[TBL] [Abstract][Full Text] [Related]
22. Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma.
Tarhini AA; Joshi I; Garner F
Immunotherapy; 2021 Aug; 13(12):1011-1029. PubMed ID: 34157863
[TBL] [Abstract][Full Text] [Related]
23. Developmental regulation of granulocyte-macrophage colony-stimulating factor production during human monocyte-to-macrophage maturation.
Krause SW; Kreutz M; Zenke G; Andreesen R
Ann Hematol; 1992 Apr; 64(4):190-5. PubMed ID: 1374650
[TBL] [Abstract][Full Text] [Related]
24. An update on sargramostim for treatment of acute radiation syndrome.
Singh VK; Seed TM
Drugs Today (Barc); 2018 Nov; 54(11):679-693. PubMed ID: 30539167
[TBL] [Abstract][Full Text] [Related]
25. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of GM-CSF production in fibroblast-monocyte coculture by prednisone and effects of rhGM-CSF on human lung fibroblasts.
Fitzgerald SM; Chi DS; Lee SA; Hall K; Krishnaswamy G
Front Biosci; 2004 Jan; 9():342-8. PubMed ID: 14766371
[TBL] [Abstract][Full Text] [Related]
27. Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells.
Tanimoto A; Murata Y; Wang KY; Tsutsui M; Kohno K; Sasaguri Y
J Biol Chem; 2008 Feb; 283(8):4643-51. PubMed ID: 18089573
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor show common biological effects and binding characteristics on human monocytes.
Elliott MJ; Vadas MA; Eglinton JM; Park LS; To LB; Cleland LG; Clark SC; Lopez AF
Blood; 1989 Nov; 74(7):2349-59. PubMed ID: 2553163
[TBL] [Abstract][Full Text] [Related]
29. Human monocyte-endothelial cell interaction induces synthesis of granulocyte-macrophage colony-stimulating factor.
Takahashi M; Kitagawa S; Masuyama JI; Ikeda U; Kasahara T; Takahashi YI; Furukawa Y; Kano S; Shimada K
Circulation; 1996 Mar; 93(6):1185-93. PubMed ID: 8653840
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.
Oehler L; Foedinger M; Koeller M; Kollars M; Reiter E; Bohle B; Skoupy S; Fritsch G; Lechner K; Geissler K
Blood; 1997 Feb; 89(4):1147-53. PubMed ID: 9028936
[TBL] [Abstract][Full Text] [Related]
31. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J
Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes.
Singh SM; Sone S; Inamura N; Ogura T
Int J Cancer; 1989 Jul; 44(1):170-6. PubMed ID: 2663733
[TBL] [Abstract][Full Text] [Related]
33. Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14
Ikezu T; Koro L; Wolozin B; Farraye FA; Strongosky AJ; Wszolek ZK
J Neuroimmune Pharmacol; 2020 Dec; 15(4):794-800. PubMed ID: 32180132
[TBL] [Abstract][Full Text] [Related]
34. Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease.
Nissen SK; Ferreira SA; Nielsen MC; Schulte C; Shrivastava K; Hennig D; Etzerodt A; Graversen JH; Berg D; Maetzler W; Panhelainen A; Møller HJ; Brockmann K; Romero-Ramos M
Mov Disord; 2021 Apr; 36(4):963-976. PubMed ID: 33332647
[TBL] [Abstract][Full Text] [Related]
35. Persistent STAT5 phosphorylation and epigenetic dysregulation of GM-CSF and PGS2/COX2 expression in Type 1 diabetic human monocytes.
Garrigan E; Belkin NS; Alexander JJ; Han Z; Seydel F; Carter J; Atkinson M; Wasserfall C; Clare-Salzler MJ; Amick MA; Litherland SA
PLoS One; 2013; 8(10):e76919. PubMed ID: 24204704
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte Macrophage Colony-Stimulating Factor-Activated CD39
Weinhage T; Däbritz J; Brockhausen A; Wirth T; Brückner M; Belz M; Foell D; Varga G
Cell Mol Gastroenterol Hepatol; 2015 Jul; 1(4):433-449.e1. PubMed ID: 28210690
[TBL] [Abstract][Full Text] [Related]
37. GM-CSF promotes migration of human monocytes across the blood brain barrier.
Vogel DY; Kooij G; Heijnen PD; Breur M; Peferoen LA; van der Valk P; de Vries HE; Amor S; Dijkstra CD
Eur J Immunol; 2015 Jun; 45(6):1808-19. PubMed ID: 25756873
[TBL] [Abstract][Full Text] [Related]
38. A monocyte gene expression signature in the early clinical course of Parkinson's disease.
Schlachetzki JCM; Prots I; Tao J; Chun HB; Saijo K; Gosselin D; Winner B; Glass CK; Winkler J
Sci Rep; 2018 Jul; 8(1):10757. PubMed ID: 30018301
[TBL] [Abstract][Full Text] [Related]
39. Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.
Blanchard DK; Michelini-Norris MB; Pearson CA; McMillen S; Djeu JY
Infect Immun; 1991 Jul; 59(7):2396-402. PubMed ID: 2050405
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation.
Nagler A; Shur I; Barak V; Fabian I
Leuk Res; 1996 Aug; 20(8):637-43. PubMed ID: 8913316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
